CAUWENBERGH GEERT 4
4 · RXi Pharmaceuticals Corp · Filed Aug 3, 2018
Insider Transaction Report
Form 4
CAUWENBERGH GEERT
DirectorPresident & CEO
Transactions
- Award
Stock option (right to buy)
2018-08-01+21,000→ 21,000 totalExercise: $1.79Exp: 2028-08-01→ Common stock (21,000 underlying) - Award
Common Stock
2018-08-01+21,000→ 35,258 total
Holdings
- 450(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]Represents shares underlying a restricted stock unit, which shares will vest in four equal annual installments.
- [F2]The stock option will vest in four equal annual installments.